Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC3 Study

Journal of Clinical Virology

Volumn 61, Issue 3, 2014, Pages 430-434

  Hajarizadeh, Behzad ^a   Grady, Bart ^b,r   Page, Kimberly ^c   Kim, Arthur Y ^d,p   McGovern, Barbara H ^e,f,p   Cox, Andrea L ^g,n   Rice, Thomas M ^c   Sacks Davis, Rachel ^h,i   Bruneau, Julie ^j,m   Morris, Meghan ^c   Amin, Janaki ^a   Schinkel, Janke ^k   Applegate, Tanya ^a   Maher, Lisa ^a,m   Hellard, Margaret ^h,i   Lloyd, Andrew R ^l,r   Prins, Maria ^b,k,r   Geskus, Ronald B ^b,k   Dore, Gregory J ^a,o   Grebely, Jason ^a,o   Lauer, Georg ^q   Shoukry, Naglaa H ^m   Hahn, Judy ^t   Shiboski, Steve ^t   Rice, T M ^t   Alavi, Maryam ^o   Bouchard, Rachel ^p   Aneja, Jasneet ^p,r   Teutsch, Suzy ^q   White, Bethany ^q   Wells, Brittany ⁿ   Zang, Geng ^m   Matthews, Gail ^o   Marks, Pip ^o   Yeung, Barbara ^o   Prince, Leslie Erin ^p   Roy, Elise ^m   Bates, Anna ^q   Enriquez, Jarliene ^q   Chow, Sammy ^q   McCredie, Luke ^q   Aitken, Campbell ^t   Doyle, Joseph ^t   Spelman, Tim ^t   Evans, Jennifer ^s   more..

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ABBVIE INC   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h BURNET INSTITUTE   (Australia)

ⁱ MONASH UNIVERSITY   (Australia)

^j CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF NEW SOUTH WALES   (Australia)

^m HEPCO   (United States)

ⁿ BBAASH   (United States)

^o ATAHC   (Australia)

^p BAHSTION   (United States)

^q HITS p   (United States)

^r Australian Computer Society Inc   (Australia)

^s UFO   (United Kingdom)

^t NONE

more..

Author keywords

Acute HCV; Cohort study; IFNL3 genotype; IL28B genotype; Viral load

Indexed keywords

HOST FACTOR; VIRUS RNA; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ACUTE DISEASE; ADULT; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERFERON LAMBDA 3 GENE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; VIRAL CLEARANCE; VIRUS GENE; VIRUS LOAD; BLOOD; COHORT ANALYSIS; COMPLICATION; GENETICS; HEPACIVIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; SUBSTANCE ABUSE; VIROLOGY; YOUNG ADULT;

ADULT; COHORT STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERLEUKINS; MALE; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD; YOUNG ADULT;

EID: 84908539060     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.08.027     Document Type: Article

References (27)

1. Glynn S.A., Wright D.J., Kleinman S.H., Hirschkorn D., Tu Y., Heldebrant C., et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005, 45:994-1002.
2. Grebely J., Page K., Sacks-Davis R., van der Loeff M.S., Rice T.M., Bruneau J., et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 2014, 59:109-120.
3. Micallef J.M., Kaldor J.M., Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006, 13:34-41.
4. Liu L., Fisher B.E., Thomas D.L., Cox A.L., Ray S.C. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 2012, 55:1684-1691.
5. Neukam K., Nattermann J., Rallón N., Rivero A., Caruz A., Macías J., et al. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype. HIV Med 2011, 12:487-493.
6. 3) study. Int J Epidemiol 2012, 42:1649-1659.
7. Hajarizadeh B., Grebely J., Applegate T., Matthews G.V., Amin J., Petoumenos K., et al. Dynamics of HCV RNA levels during acute hepatitis C virus infection. J Med Virol 2014, 86:1722-1729.
8. Hajarizadeh B., Page K., Kim A.Y., McGovern B.H., Cox A.L., Rice T.M., et al. Early HCV RNA dynamics and factors associated with high early HCV RNA level during acute HCV infection. J Hepatol 2013, 58:S470-S471. [Abstract].
9. Page-Shafer K., Pappalardo B.L., Tobler L.H., Phelps B.H., Edlin B.R., Moss A.R., et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 2008, 46:499-506.
10. Cox A.L., Netski D.M., Mosbruger T., Sherman S.G., Strathdee S., Ompad D., et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005, 40:951-958.
11. Hofer H., Watkins-Riedel T., Janata O., Penner E., Holzmann H., Steindl-Munda P., et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003, 37:60-64.
12. Busch M.P., Page Shafer K.A. Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment. Clin Infect Dis 2005, 40:959-961.
13. Badr G., Bédard N N., Abdel-Hakeem M.S., Trautmann L., Willems B., Villeneuve J.P., et al. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J Virol 2008, 82:10017-10031.
14. van de Laar T.J.W., Molenkamp R., van den Berg C., Schinkel J., Beld M.G.H.M., Prins M., et al. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J Hepatol 2009, 51:667-674.
15. Grebely J., Petoumenos K., Hellard M., Matthews G.V., Suppiah V., Applegate T., et al. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology (Baltimore, MD) 2010, 52:1216-1224.
16. Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O'hUigin C., et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461:798-801.
17. van den Berg C.H.B.S., Grady B.P.X., Schinkel J., van de Laar T., Molenkamp R., van Houdt R., et al. Female sex and IL28b, a synergism for spontaneous viral clearance in hepatitis c virus (HCV) seroconverters from a community-based cohort. PLoS ONE 2011, 6:e27555.
18. Zhang M., Rosenberg P.S., Brown D.L., Preiss L., Konkle B.A., Eyster M.E., et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 2006, 107:892-897.
19. Page K., Hahn J.A., Evans J., Shiboski S., Lum P., Delwart E., et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 2009, 200:1216-1226.
20. Thomas D.L., Astemborski J., Rai R.M., Anania F.A., Schaeffer M., Galai N., et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. J Am Med Assoc 2000, 284:450-456.
21. Tillmann H.L., Thompson A.J., Patel K., Wiese M., Tenckhoff H., Nischalke H.D., et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 2010, 139. 1586-1592.e1.
22. Harris H.E., Eldridge K.P., Harbour S., Alexander G., Teo C.G., Ramsay M.E., et al. Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?. J Viral Hepat 2007, 14:213-220.
23. McCarthy J.J., Li J.H., Thompson A., Suchindran S., Lao X.Q., Patel K., et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 2010, 138:2307-2314.
24. Uccellini L., Tseng F.C., Monaco A., Shebl F.M., Pfeiffer R., Dotrang M., et al. HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology 2012, 56:86-94.
25. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., Urban T.J., et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401.
26. Grady B.P.X., Prins M., Rebers S., Molenkamp R., Geskus R.B., Schinkel J. BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion. J Viral Hepat 2014. 2014, 10.1111/jvh.12303.
27. Hajarizadeh B., Grebely J., Dore G.J. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013, 10:553-562.